Han Sangyeul, Santos Túlio M, Puga Ana, Roy Jenn, Thiele Elizabeth A, McCollin Mia, Stemmer-Rachamimov Anat, Ramesh Vijaya
Molecular Neurogenetics Unit, Molecular Neuro-Oncology, and Department of Neurology, Harvard Medical School/Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Cancer Res. 2004 Feb 1;64(3):812-6. doi: 10.1158/0008-5472.can-03-3277.
Tuberous sclerosis complex is caused by mutations in tumor suppressor genes TSC1 or TSC2 and is characterized by the presence of hamartomas in many organs. Although tuberous sclerosis complex is a tumor suppressor gene syndrome with classic "second hits" detectable in renal tumors, conventional genetic analysis has not revealed somatic inactivation of the second allele in the majority of human brain lesions. We demonstrate a novel mechanism of post-translational inactivation of the TSC2 protein, tuberin, by physiologically inappropriate phosphorylation, which is specific to tuberous sclerosis complex-associated brain lesions. Additional analysis shows that tissue specificity is due to abnormal activation of the Akt and mitogen-activated protein kinase pathways in brain but not in renal tumors. These results have widespread implications for understanding the tissue specificity of tumor suppressor gene phenotypes.
结节性硬化症复合体由肿瘤抑制基因TSC1或TSC2的突变引起,其特征是在许多器官中存在错构瘤。尽管结节性硬化症复合体是一种肿瘤抑制基因综合征,在肾肿瘤中可检测到典型的“二次打击”,但传统的基因分析并未在大多数人脑病变中发现第二个等位基因的体细胞失活。我们证明了一种新的机制,即通过生理上不适当的磷酸化使TSC2蛋白(结节蛋白)发生翻译后失活,这是结节性硬化症复合体相关脑病变所特有的。进一步分析表明,组织特异性是由于大脑中Akt和丝裂原活化蛋白激酶途径的异常激活,而在肾肿瘤中则不然。这些结果对于理解肿瘤抑制基因表型的组织特异性具有广泛的意义。